Can-Fite Biopharma (CANF) Stock: Running For The Top On Coming Catalyst
Can-Fite Biopharma (NYSEAMERICAN: CANF) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that its data has been selected for a coming presentation, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The coming presentation; what we’re seeing … Read more